Skip to menu Skip to content Skip to footer

2005

Journal Article

Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures

Moss, S., Waller, M., Anderson, T. J. and Cuckle, H. (2005). Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures. British Journal of Cancer, 92 (5), 955-960. doi: 10.1038/sj.bjc.6602395

Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures

2004

Journal Article

Influence of annual mammography from age 40 on breast cancer pathology

Anderson, Thomas J., Waller, Michael, Ellis, Ian, O., Bobrow, Lynda and Moss, Susan (2004). Influence of annual mammography from age 40 on breast cancer pathology. Human Pathology, 35 (10), 1252-1259. doi: 10.1016/j.humpath.2004.07.011

Influence of annual mammography from age 40 on breast cancer pathology

2004

Conference Publication

Pathology results from the UK Age Trial

Ellis, I.O., Anderson, T. J., Waller, M., Bobrow, L., Hanby, A. and Moss, S. (2004). Pathology results from the UK Age Trial. Symposium Mammographicum 2004, Edinburgh, United Kingdom, 19 - 20 July 2004. London, United Kingdom: BioMed Central. doi: 10.1186/bcr850

Pathology results from the UK Age Trial

2004

Conference Publication

Interim results from the Age Trial

Moss, S., Waller, M., Anderson, T. and Cuckle, H. (2004). Interim results from the Age Trial. Symposium Mammographicum 2004, Edinburgh, United Kingdom, 19 - 20 July 2004. London, United Kingdom: BioMed Central. doi: 10.1186/bcr848

Interim results from the Age Trial

2004

Journal Article

Monitoring and evaluating the performance of the UK NHS Cervical Screening Programme: Monitoring performance by using cytology outcomes adjusted for population characteristics

Blanks, R. G., Waller, M., Sanchez-Galvez, A. and Moss, S. M. (2004). Monitoring and evaluating the performance of the UK NHS Cervical Screening Programme: Monitoring performance by using cytology outcomes adjusted for population characteristics. Cytopathology, 15 (1), 5-11. doi: 10.1111/j.1365-2303.2003.00123.x

Monitoring and evaluating the performance of the UK NHS Cervical Screening Programme: Monitoring performance by using cytology outcomes adjusted for population characteristics